These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 3974572)

  • 21. Direct actions of organophosphate anticholinesterases on nicotinic and muscarinic acetylcholine receptors.
    Bakry NM; el-Rashidy AH; Eldefrawi AT; Eldefrawi ME
    J Biochem Toxicol; 1988; 3():235-59. PubMed ID: 3236334
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Binding of [3H]perhydrohistrionicotoxin and [3H]phencyclidine to the nicotinic receptor-ion channel complex of Torpedo electroplax. Inhibition by histrionicotoxins and derivatives.
    Aronstam RS; King CT; Albuquerque EX; Daly JW; Feigl DM
    Biochem Pharmacol; 1985 Sep; 34(17):3037-47. PubMed ID: 2412560
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interactions of bupivacaine with ionic channels of the nicotinic receptor. Electrophysiological and biochemical studies.
    Ikeda SR; Aronstam RS; Daly JW; Aracava Y; Albuquerque EX
    Mol Pharmacol; 1984 Sep; 26(2):293-303. PubMed ID: 6090884
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiple binding sites for phencyclidine on the nicotinic acetylcholine receptor from Torpedo ocellata electric organ.
    Haring R; Kloog Y
    Life Sci; 1984 Mar; 34(11):1047-55. PubMed ID: 6700368
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interactions of d-tubocurarine with the nicotinic acetylcholine receptor/channel molecule.
    Shaker N; Eldefrawi AT; Aguayo LG; Warnick JE; Albuquerque EX; Eldefrawi ME
    J Pharmacol Exp Ther; 1982 Jan; 220(1):172-7. PubMed ID: 6273528
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interactions of chlordecone (kepone) and mirex with the nicotinic acetylcholine receptor--ion channel complex.
    Aronstam RS; Hong JS
    Toxicol Lett; 1986 Mar; 30(3):247-51. PubMed ID: 2422792
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oxadiazolidinones: irreversible inhibition of cholinesterases and effects on acetylcholine receptors.
    Bakry NM; Sherby SM; Eldefrawi AT; Eldefrawi ME
    Neurotoxicology; 1986; 7(3):1-10. PubMed ID: 3822252
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular mechanisms of the potent and stereospecific nicotinic receptor agonist (+)-anatoxin-a.
    Swanson KL; Allen CN; Aronstam RS; Rapoport H; Albuquerque EX
    Mol Pharmacol; 1986 Mar; 29(3):250-7. PubMed ID: 2419745
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Barbiturates bind to an allosteric regulatory site on nicotinic acetylcholine receptor-rich membranes.
    Dodson BA; Braswell LM; Miller KW
    Mol Pharmacol; 1987 Jul; 32(1):119-26. PubMed ID: 3600612
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Agonist binding to the Torpedo acetylcholine receptor. 1. Complexities revealed by dissociation kinetics.
    Dunn SM; Raftery MA
    Biochemistry; 1997 Apr; 36(13):3846-53. PubMed ID: 9092814
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation, inactivation, and desensitization of acetylcholine receptor channel complex detected by binding of perhydrohistrionicotoxin.
    Eldefrawi ME; Aronstam RS; Bakry NM; Eldefrawi AT; Albuquerque EX
    Proc Natl Acad Sci U S A; 1980 Apr; 77(4):2309-13. PubMed ID: 6246539
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulation of phencyclidine-sensitive ethidium binding to the Torpedo acetylcholine receptor: interaction of noncompetitive inhibitors with carbamylcholine and cobra alpha-toxin.
    Valenzuela CF; Kerr JA; Duvvuri P; Johnson DA
    Mol Pharmacol; 1992 Feb; 41(2):331-6. PubMed ID: 1538711
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nicotinic pharmacology of anatoxin analogs. I. Side chain structure-activity relationships at peripheral agonist and noncompetitive antagonist sites.
    Swanson KL; Aronstam RS; Wonnacott S; Rapoport H; Albuquerque EX
    J Pharmacol Exp Ther; 1991 Oct; 259(1):377-86. PubMed ID: 1920124
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Physostigmine modulation of acetylcholine currents in COS cells transfected with mouse muscle nicotinic receptor.
    Svobodová L; Krůsek J; Hendrych T; Vyskocil F
    Neurosci Lett; 2006 Jun; 401(1-2):20-4. PubMed ID: 16530961
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure of the agonist-binding sites of the Torpedo nicotinic acetylcholine receptor: affinity-labeling and mutational analyses identify gamma Tyr-111/delta Arg-113 as antagonist affinity determinants.
    Chiara DC; Xie Y; Cohen JB
    Biochemistry; 1999 May; 38(20):6689-98. PubMed ID: 10350488
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neurotransmitter receptors as targets for pesticides.
    Eldefrawi ME; Eldefrawi AT
    J Environ Sci Health B; 1983; 18(1):65-88. PubMed ID: 6339601
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The reversible cholinesterase inhibitor physostigmine has channel-blocking and agonist effects on the acetylcholine receptor-ion channel complex.
    Shaw KP; Aracava Y; Akaike A; Daly JW; Rickett DL; Albuquerque EX
    Mol Pharmacol; 1985 Dec; 28(6):527-38. PubMed ID: 2417099
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heterogeneity of high-affinity nicotinic [3H]acetylcholine binding sites.
    Lukas RJ
    J Pharmacol Exp Ther; 1990 Apr; 253(1):51-7. PubMed ID: 2329523
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Experimental autoimmune myasthenia gravis: the rabbit as an animal model.
    Eldefrawi ME
    Fed Proc; 1978 Dec; 37(14):2823-7. PubMed ID: 720635
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The interaction of anticholinesterase agents with the acetylcholine receptor-ionic channel complex.
    Albuquerque EX; Akaike A; Shaw KP; Rickett DL
    Fundam Appl Toxicol; 1984 Apr; 4(2 Pt 2):S27-33. PubMed ID: 6327444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.